Nanoporous Silica Particles for Enhanced Drug Performance: Applications Beyond Increasing Solubility

  • Nanologica’s nanoporous silica technology is a versatile drug delivery platform that addresses formulation challenges for improved clinical benefit
  • Key applications of NLAB SilicaTM are enhancing bioavailability, overcoming pH-dependent solubility issues and improving PK variability
  • Two case studies of reformulating anti-infectives with NLAB SilicaTM will illustrate how a Drug Delivery technology can be used for repurposing of marketed drugs
  • How value can be maximised by the right collaboration models between technology partner and pharma Company

Nanologica @ DDF Summit Boston